DM-Pharma
ActiveThe computed 12-month bankruptcy probability of DM-Pharma is 1.9% (moderate). The 2024 annual accounts show equity of €77k and a net result of €28k. Equity is growing by ~29.1% per year across the filed fiscal years. Its solvency ranks better than 50% of 26056 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
86
/ 100
Excellent▲ +66 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100▲+100
Solvency58▲+30
Growth52=
Stability94
Bankruptcy probability, 12 months
1.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.36 against 0.68 in 2023), and 68.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
31.8%
Return on assets
11.5%
Age of the figures
20 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 21-06-2025, 40 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
not confirmed
2024
40 d early
2023
23 d late
2022
31 d early
2021
34 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€77k▲ 56.4%
2023 · €49k
2021: €31k
2022: €50k
2023: €49k
2021 → 2024
Total assets
€241k▲ 17.4%
2023 · €205k
2021: €53k
2022: €203k
2023: €205k
2021 → 2024
Net result
€28k
2023 · €-610
2021: €28k
2022: €19k
2023: €-610
2021 → 2024
Working capital
€16k
2023 · €-10k
2021: €32k
2022: €19k
2023: €-10k
2021 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2021202220232024Trend
Equity€31k-€50k▲ 59.6%€49k▼ 1.2%€77k▲ 56.4%
Operating result€39k-€28k▼ 29.4%€6k▼ 78.5%€44k▲ 634%
Net result€28k-€19k▼ 34.0%€-610€28k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 634% above 2023 and is the highest year so far.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €241k
Fixed assets
€180k▼ 2.1%
Current assets
€61k▲ 183%
Equity and liabilities €241k
Equity
€77k▲ 56.4%
Debt
€164k▲ 5.2%
The debt ratio falls from 76.1% to 68.2%: equity grows faster than debt.
Key figures and ratios
EBITDA
€51k▲
2023 · €13k
Cash flow
€35k▲
2023 · €6k
Solvency
31.8%▲
2023 · 23.9%
Current ratio
1.36▲
2023 · 0.68
Quick ratio
1.36▲
2023 · 0.68
Debt / equity
2.15▼
2023 · 3.19
ROE
36.1%▲
2023 · -1.2%
ROA
11.5%▲
2023 · -0.3%
Interest coverage
6.34▲
2023 · 2.28
Debt
€164k▲
2023 · €156k
Debt ≤ 1 year
€45k▲
2023 · €32k
Debt > 1 year
€118k▼
2023 · €124k
Income taxes
€8k▲
2023 · €965
Staff costs
€0▼
2023 · €152
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€205k€241k▲
Fixed assets21/28€183k€180k▼
Tangible fixed assets22/27€183k€180k▼
Land and buildings22€183k€180k▼
Current assets29/58€22k€61k▲
Amounts receivable within one year40/41€15k€58k▲
Trade receivables40€12k€56k▲
Other amounts receivable41€3k€3k▼
Cash at bank and in hand54/58€5k€2k▼
Deferred charges and accrued income490/1€1k€1k▲
Equity and liabilities
Total equity and liabilities10/49€205k€241k▲
Equity10/15€49k€77k▲
Contributions10/11€3k€3k=
Reserves13€47k€47k=
Distributable reserves133€47k€47k=
Profit (loss) carried forward14€-610€27k▲
Amounts payable17/49€156k€164k▲
Amounts payable after more than one year17€124k€118k▼
Financial debts170/4€124k€118k▼
Amounts payable within one year42/48€32k€45k▲
Current portion of amounts payable after more than one year42€6k€6k▲
Financial debts43-€4k
Credit institutions430/8-€4k
Trade debts44€4k€3k▼
Suppliers440/4€4k€3k▼
Taxes, remuneration and social security45€11k€17k▲
Taxes450/3€11k€17k▲
Other amounts payable47/48€11k€15k▲
Accrued charges and deferred income492/3€423€1k▲
Income statement
Code20232024
Remuneration, social security and pensions62€152€0▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7k€8k▲
Other operating charges640/8€1k€1k▲
Gross operating margin9900€14k€53k▲
Operating profit (loss)9901€6k€44k▲
Financial charges65/66B€6k€8k▲
Recurring financial charges65€6k€8k▲
Profit (loss) for the period before taxes9903€355€36k▲
Income taxes67/77€965€8k▲
Profit (loss) for the period9904€-610€28k▲
Profit (loss) for the period to be appropriated9905€-610€28k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-610€27k▲
Profit (loss) brought forward from the previous period14P-€-610
Transfer to equity691/2€0-
To other reserves6921€0-
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
24-03
State Gazette act
Registered officeBoard meeting · Registered-office move2 facts ▸
State Gazette act
Registered office
Board meeting · Registered-office move2 facts ▸
- Board meeting, 09/12/2025
- Registered-office move, Terrasstraat 39, 9400 Appelterre
2025
21-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Back to profitnet €28k
Net result €28k after one loss-making year.
31-12
Financial
Liquidity doublescurrent ratio 1.36
Current ratio from 0.68 to 1.36.
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 23 days late
2023
31-12
Financial
Weakest financial yearnet €-610 ▼103%
Net result drops to €-610, the lowest in the series; recovery starts the following year.
30-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
27-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 1. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ninove · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Terrasstraat(App) 399400 NinoveGround area
1,780 m²
Building footprint
200 m²
Parcel 41003B1187/00F000, Flanders. Linked by address, not a title deed.
1 establishment unit
DM-Pharma
since 20212.311.662.230
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41003B1187/00F000 | Flanders | 1,780 m² | 1 · 200 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMACIE THAUVIN
BE 0693.816.452
Ciney · Eq €77k
PHARMACIE DUVAL
BE 0885.923.071
Verviers · Eq €77k
No-Ci
BE 0779.434.689
Sint-Niklaas · Eq €77k
APOTHEEK MEES SINT-TRUIDEN
BE 0439.019.228
Sint-Truiden · Eq €76k
APR. GEERTS CHARLOTTE
BE 0822.177.245
Puurs-Sint-Amands · Eq €76k
Of 5,208 companies in sector 47730 we hold annual accounts for 3,850. 3,203 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-01-2021
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
63920Other information service activities
63990Computing infrastructure, data processing, hosting and other information service activities
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 11-09-2026. Scores and ratios are computed by Checked and are not a credit decision.